Tag Archive for: AMSilk

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

/in

First patent application registered BRAIN Biotech relies on protein engineering expertise and bioinformatics for rational protein design Zwingenberg / Neuried (Germany), March 5, 2024 – BRAIN Biotech AG, leading provider of solutions for the biologization of industry, and AMSilk GmbH, a global leader in advanced materials made from spider silk-based proteins, announce the successful completion […]

Read more

AMSilk and 21st.BIO announce partnership to accelerate the production of advanced materials made from spider silk-based proteins

/in

New protein production strain delivers unprecedented yield with greater efficiency and lower costs Neuried, Germany, and Copenhagen, Denmark, 17 January 2024 – AMSilk, a global leader in advanced materials made from spider silk-based proteins, and 21st.BIO, a leader in bioproduction, today announced that they have joined forces to accelerate the upscaling of AMSilk’s silk protein […]

Read more

AMSilk appoints Gudrun Vogtentanz as Chief Scientific Officer

/in

Munich, 17 October, 2023: AMSilk GmbH (“AMSilk”), the world’s first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO). Gudrun will be responsible for AMSilk’s protein and strain strategy as well as bridging science and business development. With many years of experience in biotechnology research, Gudrun has a […]

Read more

AMSilk to join panel at SynBioBeta Global Synthetic Biology Conference

/in

Munich, Germany, 17 May, 2023: AMSilk GmbH (“AMSilk”), the world’s first industrial supplier of bio-fabricated silk protein materials, today announces it will be attending the SynBioBeta Global Synthetic Biology Conference in California from 23-25 May 2023. AMSilk will be introducing its outstanding technology, based on silk proteins. Ulrich Scherbel, Chief Executive Officer of AMSilk will […]

Read more

AMSilk Announces Extension of Series C Financing to EUR 54M

/in

Funding enables AMSilk to accelerate industrial scale-up and expand commercial operations of bio-fabricated silk protein materials Financing led by existing investors ATHOS (AT Newtec) with participation from Novo Holdings, Cargill, and MIG Capital. Munich, 4. April, 2023: AMSilk GmbH (“AMSilk”), the world’s first industrial supplier of bio-fabricated silk protein materials, today announced it has successfully raised […]

Read more